Humanised Mouse Models for Immuno-Oncology: Infectious and Inflammatory Diseases
TransCure bioServices
Service ID:
EP324S1This service provides customised preclinical studies using CD34+and PBMC humanised mouse models to evaluate innovative therapies in immuno-oncology, infectious, and inflammatory disease areas. The target audiences are biotech and pharmaceutical SMEs developing biologics, cell therapies, antibodies, and small molecules. The goal is to assess efficacy, safety, mechanism of action, and human immune responses in translational models. Activities cover study design, humanisation/engraftment, treatment administration, longitudinal monitoring, immune profiling (e.g., flow cytometry, cytokines), histopathology, data analysis andreporting. The expected outcomes of the service are decision-grade evidence for candidate selection and progression. Implementation is done in-house by TCS scientific experts (immunology, virology, inflammation), with full oversight and a complete study data package delivered to the beneficiary. The typical duration of the service is 8–12 weeks, depending on study design and endpoints.
Price starting from €1600/mouse. Pricing per mouse, including study design, experimental work in vivo and in vitro, data analysis, and reporting, is tailored based on the specific details, mouse model selected, and scope/duration of the requested project.
Are you in doubt if this is the right service for you, or do you want to get more information about the service? Get in touch with the EIC Partner providing this service through this query form!
Is this the service you are looking for? If so, you can apply to the service through EIC ACCESS+! Eligible applicants can also get co-funding through the EIC ACCESS+ initiative. Find out more on the project webiste.
Receive up to €60,000 in grants, covering up to 50% of the costs, to access specialised services from the EIC Service Catalogue. Learn more on the EIC ACCESS+ website.